Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 14/20 | 0.57 |
| ▸ | ADRB1 | P08588 | 14/20 | 0.57 |
| ▸ | ADRA1D | P25100 | 14/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 14/20 | 0.57 |
| ▸ | ADRA1B | P35368 | 14/20 | 0.57 |
| ▸ | ADRB3 | P13945 | 13/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.56 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.56 |
| ▸ | HTR1A | P08908 | 1/20 | 0.56 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.56 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.56 |
| ▸ | DRD3 | P35462 | 1/20 | 0.56 |
| ▸ | HTR2B | P41595 | 1/20 | 0.56 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11597558 | 0.83 | ADRA1D (0.54) | ADRB2ADRB1ADRA1DADRA1AADRA1B | |
| SCHEMBL5353150 | 0.83 | KDM4E (0.44) | ADRB2ADRB1ADRA1DADRA1AADRA1B | |
| SCHEMBL3978402 | 0.82 | ADRA1D (0.45) | ADRB2ADRB1ADRA1DADRA1AADRA1B | |
| SCHEMBL11354288 | 0.81 | ADRB1 (0.63) | ADRB2ADRB1ADRA1DADRA1AADRA1B | |
| SCHEMBL11349295 | 0.81 | ADRB1 (0.63) | ADRB2ADRB1ADRA1DADRA1AADRA1B | |
| SCHEMBL5347615 | 0.81 | MAOB (0.52) | ADRB2ADRB1ADRA1DADRA1AADRA1B | |
| SCHEMBL5347623 | 0.81 | MAOB (0.52) | ADRB2ADRB1ADRA1DADRA1AADRA1B | |
| SCHEMBL5359397 | 0.81 | MAOB (0.52) | ADRB2ADRB1ADRA1DADRA1AADRA1B | |
| SCHEMBL11597561 | 0.81 | L3MBTL1 (0.45) | ADRB2ADRB1ADRA1DADRA1AADRA1B | |
| Hydrochloric Acid SCHEMBL11357232 | 0.80 | ADRB1 (0.64) | ADRB2ADRB1ADRA1DADRA1AADRA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7538127-B2 | Medicinal compounds | GLAXO GROUP LIMITED (GB) | 2009-05-26 | — | — | US | disclosed |
| EP-1554264-B1 | MEDICINAL ARYLETHANOLAMINE COMPOUNDS | GLAXO GROUP LTD (GB) | 2007-08-08 | — | — | EP | disclosed |
| US-20060205790-A1 | Medicinal arylethanolamine compounds | GLAXO GROUP LIMITED (GB) | 2006-09-14 | — | — | US | disclosed |
| US-20060148771-A1 | Medicinal compounds | GLAXO GROUP LIMITED (GB) | 2006-07-06 | — | — | US | disclosed |
| EP-1592656-A2 | MEDICINAL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2005-11-09 | — | — | EP | disclosed |
| EP-1554264-A2 | MEDICINAL ARYLETHANOLAMINE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2005-07-20 | — | — | EP | disclosed |
| WO-2004071388-A2 | MEDICINAL COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2004-08-26 | — | — | WO | disclosed |
| WO-2004037807-A9 | MEDICINAL ARYLETHANOLAMINE COMPOUNDS | GLAXO GROUP LTD (GB) | 2004-08-19 | — | — | WO | disclosed |
| WO-2004037807-A2 | MEDICINAL ARYLETHANOLAMINE COMPOUNDS | GLAXO GROUP LIMITED (GB) | 2004-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060148771-A1 | Medicinal compounds | AVPR1B, AVPR2, CYP11B1 | ADRB2 98/4885ADRB1 16/4885ADRA1D 19/4885 |
| US-20060205790-A1 | Medicinal arylethanolamine compounds | NAT1, AADAC, AHR | ADRB2 117/4885ADRB1 120/4885ADRA1D 202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.